August 3, 2021 Comments Off on New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA Posted in: Uncategorized
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Glaxosmithkline drug ARN…
August 3, 2021 Comments Off on New patent expiration for Mylan Speciality drug ELESTRIN Posted in: Uncategorized
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared firs…
